Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P21
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -52.11% |
| 2024 | -32.38% |
| 2023 | -67.66% |
| 2022 | 125.18% |
| 2021 | 226.54% |
| 2020 | 192.32% |
| 2019 | 251.49% |
| 2018 | -87.57% |
| 2017 | -78.67% |
| 2016 | 84.61% |